# Oak Valley Bancorp: financial statements, quarterly

OVLY · Nasdaq · CIK 1431567 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ovly.md) · [Financials](/companies/ovly/financials.md) · [Filings](/companies/ovly/filings.md) · [Insiders](/companies/ovly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ovly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [1,411](/filings/0001437749-23-031833.md) | [2,305 d](/filings/0001437749-24-010372.md) | [2,751](/filings/0001437749-24-016516.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [2,272](/filings/0001437749-24-034865.md) | [1,914 d](/filings/0001437749-25-010215.md) | [1,504](/filings/0001437749-25-016795.md) | [1,547](/filings/0001437749-25-026558.md) | [2,473](/filings/0001437749-25-034791.md) | [1,720 d](/filings/0001437749-26-009757.md) | [1,499](/filings/0001437749-26-016466.md) | [1,581](/filings/0001437749-26-027900.md) | [1,837](/filings/0001437749-25-034791.md) | [1,820 d](/filings/0001437749-26-009757.md) | [1,497](/filings/0001437749-26-016466.md) | [1,317](/filings/0001437749-26-027900.md) |
| Net income | $k | [7,354](/filings/0001437749-24-034865.md) | [5,865 d](/filings/0001437749-25-010215.md) | [5,727](/filings/0001437749-25-016795.md) | [5,889](/filings/0001437749-25-026558.md) | [7,324](/filings/0001437749-25-034791.md) | [6,008 d](/filings/0001437749-26-009757.md) | [5,297](/filings/0001437749-26-016466.md) | [5,588](/filings/0001437749-26-027900.md) | [6,693](/filings/0001437749-25-034791.md) | [6,335 d](/filings/0001437749-26-009757.md) | [5,309](/filings/0001437749-26-016466.md) | [5,114](/filings/0001437749-26-027900.md) |
| Diluted EPS | $ per share | [0.89](/filings/0001437749-24-034865.md) | not reported | [0.69](/filings/0001437749-25-016795.md) | [0.71](/filings/0001437749-25-026558.md) | [0.89](/filings/0001437749-25-034791.md) | not reported | [0.64](/filings/0001437749-26-016466.md) | [0.67](/filings/0001437749-26-027900.md) | [0.81](/filings/0001437749-25-034791.md) | not reported | [0.64](/filings/0001437749-26-016466.md) | [0.61](/filings/0001437749-26-027900.md) |
| Basic EPS | $ per share | [0.90](/filings/0001437749-24-034865.md) | not reported | [0.70](/filings/0001437749-25-016795.md) | [0.72](/filings/0001437749-25-026558.md) | [0.89](/filings/0001437749-25-034791.md) | not reported | [0.64](/filings/0001437749-26-016466.md) | [0.68](/filings/0001437749-26-027900.md) | [0.81](/filings/0001437749-25-034791.md) | not reported | [0.64](/filings/0001437749-26-016466.md) | [0.62](/filings/0001437749-26-027900.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [278](/filings/0001437749-23-031833.md) | [217](/filings/0001437749-25-010215.md) | [170](/filings/0001437749-24-016516.md) | [180](/filings/0001437749-24-026708.md) | [214](/filings/0001437749-24-034865.md) | [169](/filings/0001437749-26-009757.md) | [209](/filings/0001437749-25-016795.md) | [199](/filings/0001437749-25-026558.md) | [247](/filings/0001437749-25-034791.md) | [232](/filings/0001437749-26-027900.md) | [202](/filings/0001437749-26-016466.md) | [195](/filings/0001437749-26-027900.md) |
| Total assets | $m | [1,835](/filings/0001437749-23-031833.md) | [1,842](/filings/0001437749-25-010215.md) | [1,806](/filings/0001437749-24-016516.md) | [1,841](/filings/0001437749-24-026708.md) | [1,900](/filings/0001437749-24-034865.md) | [1,901](/filings/0001437749-26-009757.md) | [1,924](/filings/0001437749-25-016795.md) | [1,921](/filings/0001437749-25-026558.md) | [1,995](/filings/0001437749-25-034791.md) | [2,023](/filings/0001437749-26-027900.md) | [2,010](/filings/0001437749-26-016466.md) | [2,002](/filings/0001437749-26-027900.md) |
| Total liabilities | $m | [1,700](/filings/0001437749-23-031833.md) | [1,676](/filings/0001437749-25-010215.md) | [1,639](/filings/0001437749-24-016516.md) | [1,669](/filings/0001437749-24-026708.md) | [1,715](/filings/0001437749-24-034865.md) | [1,717](/filings/0001437749-26-009757.md) | [1,741](/filings/0001437749-25-016795.md) | [1,735](/filings/0001437749-25-026558.md) | [1,797](/filings/0001437749-25-034791.md) | [1,815](/filings/0001437749-26-027900.md) | [1,804](/filings/0001437749-26-016466.md) | [1,785](/filings/0001437749-26-027900.md) |
| Shareholders' equity | $m | [135](/filings/0001437749-24-034865.md) | [166](/filings/0001437749-26-009757.md) | [167](/filings/0001437749-25-026558.md) | [172](/filings/0001437749-25-034791.md) | [185](/filings/0001437749-25-034791.md) | [183](/filings/0001437749-26-027900.md) | [184](/filings/0001437749-26-027900.md) | [186](/filings/0001437749-26-027900.md) | [198](/filings/0001437749-25-034791.md) | [208](/filings/0001437749-26-027900.md) | [206](/filings/0001437749-26-027900.md) | [217](/filings/0001437749-26-027900.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,244 d](/filings/0001437749-24-034865.md) | [8,522 d](/filings/0001437749-25-010215.md) | [8,284](/filings/0001437749-25-016795.md) | [4,167 d](/filings/0001437749-25-026558.md) | [8,930 d](/filings/0001437749-25-034791.md) | [4,255 d](/filings/0001437749-26-009757.md) | [8,242](/filings/0001437749-26-016466.md) | [5,829 d](/filings/0001437749-26-027900.md) | [6,619 d](/filings/0001437749-25-034791.md) | [7,977 d](/filings/0001437749-26-009757.md) | [8,057](/filings/0001437749-26-016466.md) | [3,614 d](/filings/0001437749-26-027900.md) |
| Capital expenditure | $k | [34.0 d](/filings/0001437749-24-034865.md) | [253 d](/filings/0001437749-25-010215.md) | [138](/filings/0001437749-25-016795.md) | [590 d](/filings/0001437749-25-026558.md) | [183 d](/filings/0001437749-25-034791.md) | [868 d](/filings/0001437749-26-009757.md) | [1,179](/filings/0001437749-26-016466.md) | [1,584 d](/filings/0001437749-26-027900.md) | [790 d](/filings/0001437749-25-034791.md) | [555 d](/filings/0001437749-26-009757.md) | [212](/filings/0001437749-26-016466.md) | [230 d](/filings/0001437749-26-027900.md) |
| Dividends paid | $k | [1,325 d](/filings/0001437749-24-034865.md) | [0.0 d](/filings/0001437749-25-010215.md) | [1,866](/filings/0001437749-25-016795.md) | [0.0 d](/filings/0001437749-25-026558.md) | [1,881 d](/filings/0001437749-25-034791.md) | [0.0 d](/filings/0001437749-26-009757.md) | [2,507](/filings/0001437749-26-016466.md) | [0.0 d](/filings/0001437749-26-027900.md) | [2,515 d](/filings/0001437749-25-034791.md) | [0.0 d](/filings/0001437749-26-009757.md) | [3,146](/filings/0001437749-26-016466.md) | [0.0 d](/filings/0001437749-26-027900.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,206](/filings/0001437749-23-031833.md) | [8,227](/filings/0001437749-24-016516.md) | [8,227](/filings/0001437749-24-026708.md) | [8,232](/filings/0001437749-24-034865.md) | [8,245](/filings/0001437749-25-016795.md) | [8,248](/filings/0001437749-25-026558.md) | [8,264](/filings/0001437749-25-034791.md) | [8,278](/filings/0001437749-26-016466.md) | [8,285](/filings/0001437749-26-027900.md) | [8,299](/filings/0001437749-25-034791.md) | [8,322](/filings/0001437749-26-016466.md) | [8,333](/filings/0001437749-26-027900.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,412,708 at 2026-07-27, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-027900.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.